Showing results (101-110 of 140) with videos related to
Sort By:
Pageof 14
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2025
Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Phase II Multicenter TrialSehhoon Park, Hee Kyung Ahn, Seoyoung Lee, et al.Molecular Cancer Therapeutics|July 26, 2015
Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung AdenocarcinomaChan Woo Kang, Kang Won Jang, Jinyoung Sohn, et al.Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer modelsHan Na Kang, Se-Ho Kim, Mi Ran Yun, et al.Journal for Immunotherapy of Cancer|July 31, 2020
Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in <i>ALK</i>-positive non-small-cell lung cancerKyoung-Ho Pyo, Sun Min Lim, Chae-Won Park, et al.Thoracic Cancer|April 5, 2016
Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational studySun Min Lim, Byeong Bae Park, Keun-Chil Park, et al.Frontiers in Oncology|November 12, 2024
Neoadjuvant chemotherapy followed by definitive local treatment in locally advanced sinonasal squamous cell carcinomaJina Kim, Min Hee Hong, Hye Ryun Kim, et al.Cancers|July 9, 2020
Prognostic Value of <i>CD200R1</i> mRNA Expression in Head and Neck Squamous Cell CarcinomaHyun Chang, Yun-Gyoo Lee, Yoon Ho Ko, et al.Lung Cancer (Amsterdam, Netherlands)|March 21, 2013
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancerSeungtaek Lim, Byoung Chul Cho, Ji Ye Jung, et al.Lung Cancer (Amsterdam, Netherlands)|January 28, 2014
Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinomaMin Hwan Kim, Hyo Sup Shim, Dae Ryong Kang, et al.Cancers|September 28, 2023
Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic StrategiesYoungtaek Kim, Joon Yeon Hwang, Dong Kwon Kim, et al.Pageof 14